Terminology Service < Semantic Lookup Platform

All terms in EFO

Label	Id	Description
response to sulfasalazine	EFO_0008324	[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a sulfasalazine stimulus. Sulfasalazine is a drug used to treat rheumatoid arthritis, ulcerative colitis and Crohn's disease.]
obsolete_epidermolysis bullosa simplex	Orphanet_304
response to sotalol	EFO_0008325	[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a sotalol stimulus. Sotalol is a beta-adrenergic receptor blocker that is used to treat heart arrhythmias]
Dystrophic epidermolysis bullosa	Orphanet_303	[Dystrophic epidermolysis bullosa (DEB) is a form of inherited epidermolysis bullosa (EB) characterized by cutaneous and mucosal fragility resulting in blisters and superficial ulcerations that develop below the lamina densa of the cutaneous basement membrane and that heal with significant scarring and milia formation. It comprises ten sub-types with the three most common being generalized dominant DEB (DDEB), severe generalized recessive DEB (RDEB- sev gen) and RDEB generalized-other (see these terms).]
fibrodysplasia ossificans progressiva	MONDO_0007606	[Fibrodysplasia ossificans progressiva (FOP) is a severely disabling heritable disorder of connective tissue characterized by congenital malformations of the great toes and progressive heterotopic ossification that forms qualitatively normal bone in characteristic extraskeletal sites.]
a disintegrin and metalloproteinase with thrombospondin motifs 5 measurement	EFO_0008326	[quantification of the amount of a disintegrin and metalloproteinase with thrombospondin motifs 5 in a sample]
obsolete_epidermodysplasia verruciformis	Orphanet_302
femoral-facial syndrome	MONDO_0007604	[Femoral-facial syndrome is characterized by predominant femoral hypoplasia (bilateral or unilateral) and unusual facies.]
white matter volume measurement	EFO_0008320	[quantification of the volume of white matter in the brain, usually through an MRI scan]
obsolete_Bifunctional enzyme deficiency	Orphanet_300
WNT1-inducible-signaling pathway protein 1 measurement	EFO_0008321	[quantification of the amount of WNT1-inducible-signaling pathway protein 1 in a sample]
decreased susceptibility to bacterial infection	EFO_0008322	[reduced likelihood that an organism will develop ill effects from a bacterial infection or from components of or toxins produced by bacteria]
stress-induced anxiety-like behavior	EFO_1001920
pathological	PATO_0001869	[A quality inhering in a bearer by virtue of the bearer's being abnormal and having a destructive effect on living tissue.]
alpha-1-antitrypsin measurement	EFO_0008327	[quantification of the amount of alpha-1-antitrypsin in a sample]
chronotype measurement	EFO_0008328	[quantification of some aspect of chronotype such as ease of getting up in the morning]
circadian rhythm	EFO_0004354	[The regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs and stimuli, hormone secretion, sleeping, and feeding.]
facial emotion recognition measurement	EFO_0008329	[quantification of some aspect of facial emotion recognition such as ability to differentiate between different emotions]
X-06350 measurement	EFO_0021202	[Quantification of the amount of X-06350 in a sample.]
X-06307 measurement	EFO_0021201	[Quantification of the amount of X-06307 in a sample.]